Clinical Trials Directory

Trials / Completed

CompletedNCT02864823

Perichondrium Autograft in Refractory Necrotizing Scleritis

Autologous Perichondrium Transplantation for Replacement of Stem Cells and Their Niche in the Treatment of Necrotizing Scleritis

Status
Completed
Phase
N/A
Study type
Interventional
Enrollment
20 (actual)
Sponsor
Chung-Ang University Hosptial, Chung-Ang University College of Medicine · Academic / Other
Sex
All
Age
Healthy volunteers
Not accepted

Summary

Necrotizing scleritis with severe ischemia is refractory to conventional treatment because of avascular necrosis. The investigators assessed the therapeutic efficacy and safety of autologous perichondrium transplantation in patients with severe ischemic necrotizing scleritis, and analyzed the therapeutic effects.

Detailed description

Ischemic necrotizing scleritis patients who showed persistent and progressive scleral melting were included in this study. Perichondrium tissue was harvested from the patient's ear cartilage and transplanted to reconstruct the scleral defect after the necrotic tissue removal.

Conditions

Interventions

TypeNameDescription
PROCEDUREPerichondrium AutograftsPerichondrium tissue was harvested from the patient's ear cartilage and transplanted to reconstruct the scleral defect.

Timeline

Start date
2011-03-01
Primary completion
2016-06-01
Completion
2016-06-01
First posted
2016-08-12
Last updated
2016-08-12

Locations

1 site across 1 country: South Korea

Source: ClinicalTrials.gov record NCT02864823. Inclusion in this directory is not an endorsement.